Back to mobile site

Barclays Maintains an 'Overweight' on Laboratory Corporation (LH); June Quarter Review - After the Call

July 22, 2011 2:47 PM EDT
Get Alerts LH Hot Sheet
Price: $332.81 --0%

Rating Summary:
    22 Buy, 14 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 5 | New: 23
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Laboratory Corporation of America (NYSE: LH) price target of $115.00.

Barclays analyst says, "The quarter was solid and was a clean beat, with the company delivering better-than-expected revenue (on both volumes and pricing) EBITDA and EPS. Revenue was up a strong 13.3%, driven by a 4.8% increase in volumes and an 8.1% increase in pricing...Finally, we highlight that LabCorp maintained its full-year revenue and cash EPS guidance of $6.17-6.32. Nonetheless, we believe the company's commentary on the call around guidance has created some concern in the marketWe believe these concerns are overdone and are reiterating our 2011 and 2012 Cash EPS estimates of $6.27 and $7.20, respectively."

For more ratings news on Laboratory Corporation of America click here and for the rating history of Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $94.47 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Barclays